High-Dose MTX Does Not Reduce CNS Relapse in Pediatric ALL High-Dose MTX Does Not Reduce CNS Relapse in Pediatric ALL
The UKALL2011 study also showed that a shorter course of dexamethasone did not reduce toxicities, and that monthly pulses of vincristine/dexamethasone don ' t reduce bone marrow relapse.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Dexamethasone | Health | Hematology | Pediatrics | Study | Toxicology